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Artery From Segmental Arterial Mediolysis: A Case Report and Review
of the Literature
Michael N. Tameo, Matthew J. Dougherty, MD, and Keith D. Calligaro,
MD, Pennsylvania Hospital, Philadelphia, Pa
Background: Spontaneous dissection of the superior mesenteric artery
(SMA) is rare. We report a case of rupture of the SMA after spontaneous
dissection in a 51-year-old man who presented with acute onset of abdom-
inal pain and hypotension. The patient was diagnosed as having segmental
arterial mediolysis (SAM).
Case: The patient was initially treated with intravenous fluid resuscita-
tion and endovascular intervention, followed by open surgery. The relevant
features of the case as well as SAM are presented. In addition, a review of all
available published literature on SAM to date is presented. No identifiable
cause for dissection was found. The patient was diagnosed as having SAM.
He did well and was discharged home on postoperative day 8. A follow-up
CT scan showed additional disease characteristic of SAM in a branch of the
inferior mesenteric artery that was treated with coil embolization.
Conclusions: SAM is a rare arteriopathy of unknown etiology. Differ-
ential diagnosis includes fibromuscular dysplasia and inflammatory arteritis
such as polyarteritis nodosa. Differentiation is important, because there is no
standard treatment for SAM.
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In Vivo Evaluation of a Hand-Held, Battery-Operated Therapeutic
Ultrasound Device for the Noninvasive Treatment of Varicose Veins
Peter W. Henderson, MD MBA, Allie M. Sohn, BS, Aleid Koppius, BS,
George K. Lewis, Jr, BS, William L. Olbricht, PhD, and Jason A. Spector,
MD, Weill Cornell Medical College, New York, NY, and Ithaca, NY
Objectives: Current treatments for varicose veins and other vascular
malformations are to some degree invasive and may therefore be painful and
associated with complications such as infection, thrombophlebitis, and
bleeding. The development of entirely noninvasive techniques has been
hampered by the high cost, large size, and power requirements of candidate
technologies, such as high-intensity focused ultrasound (HIFU) imaging.
Our group has developed a HIFU device that is hand-held and battery-
operated, and we have previously demonstrated that it is capable of venous
ablation ex vivo. The purpose of this study was to determine whether it is
capable of transcutaneous venous ablation in vivo.
Methods:Our HIFU device weighs 560 grams and has an intensity of
2500W/cm2 that focuses at a focal length of 3.3 mm. Amidline laparotomy
was performed on four Sprague-Dawley rats to expose the IVC. The HIFU
transducer was covered in a plane 2 mm from the focal point with a piece of
previously harvested rat skin, and under direct visualization, the device was
applied to the IVC and activated for 60 seconds.
Results: Compared with the condition of the IVC before HIFU
treatment, the IVC after HIFU was marked by significant contraction and
coagulation necrosis. There was no antegrade blood flow from the IVC after
transection at the level immediately superior to the treated area, indicating
complete venous occlusion. Furthermore, there was no evidence of necrosis
in any of the adjacent tissues.
Conclusions: In contrast to previous HIFU devices, ours is hand-held,
portable, and relatively inexpensive. Although subsequent prototypes will
incorporate visualization capabilities, the current device required a modified
experimental design that allowed for direct visualization while assessing the
ability to effectively ablate veins in a transcutaneous fashion. Our results
indicate that this device is capable of successful, targeted, transcutaneous
venous ablation in vivo. Because this technique is completely noninvasive, it
has the potential to minimize the visible scars and other complications that
can be associated with more invasive procedures. Accordingly, we believe
that interventions based upon this technology may provide a superior
treatment option for varicosities and other vascular malformations.
Regulation of Membrane-Type Matrix Metalloproteinase Expression
by Recanalization and Flow During Thrombus Resolution
Mohammed Chaudry, MD, Christine Chabasse, PhD, and Rajabrata Sarkar,
MD, PhD, University of Maryland, Baltimore, Md
Objectives: Expression and activity of matrix metalloproteinase
(MMP) enzymes is important in the process of venous thrombus resolution.
Expression of the membrane-type MMP family of genes (MT-MMPs) in
thrombus resolution, and the regulation of their expression by blood flow
(recanalization) remain undefined. We tested the hypothesis that thrombus
resolution would activate these genes and that recanalization would further
regulate their expression.
Methods: CD1 mice underwent surgical inferior vena cava (IVC)
ligation (stasis thrombosis), IVC stenosis (thrombosis with recanalization),
or a sham procedure. We analyzed thrombus weight over time as a measure
of thrombus resolution, and studied mRNA levels of MT-MMP genes by
real-time PCR of mRNA extracted from thrombus  vein wall, as well asprotein expression by Western blotting and immunohistochemistry. Statis-
tical analysis was by ANOVA and t test (P  .05).
Results: Thrombus resolution was 28% and 32% greater (P  .05) in
the stenosis vs the ligation model on postoperative day (POD) 8 and 12 (n
 5-13). Thrombus resolution induced MT-1 (4-fold vs sham on POD 8
 12; P  .05) but the stenosis model demonstrated a more significant
induction early (1.83 vs 1.15, POD4; P  .05). Thrombus resolution
repressed MT-2 expression (0.2-fold, POD4; P  .05) in both stasis and
recanalization models, and initially induced (8-fold, POD4; P  .05) but
then repressed MT-5 and MT-6 expression. MT-4 expression increased late
(2.8-fold, POD12; P  .05) selectively in the stasis model, whereas MT-3
had the opposite induction only in the recanalization model (2-fold; P 
.05). Pro- and activeMMP2 protein and gelatinase activity were increased in
recanalization stasis sham. MT1 and MT3 expression localized around
areas of recanalization during thrombus resolution.
Conclusions: These studies demonstrate that the expression of MT-
MMP family of genes is differentially induced and repressed during the
process of thrombus resolution, further localized in focal areas of recanali-
zation within the thrombus. These findings increase our knowledge of the
biology of venous thrombus resolution and identify pathways that may serve
as therapeutic targets to accelerate thrombus resolution.
Human Adult Stem Cells Restore Endothelial Migratory Dysfunction
in a Hypoxic Environment
Sarah Fernandez, MD, Rachel Song, BS, Jason Comeau, MD, Stephen
McIlhenny, PhD, Hamid Abdollahi, MD, Ping Zhang, PhD, Thomas N.
Tulenko, PhD, and Paul J. DiMuzio, MD, Thomas Jefferson University
Hospital, Philadelphia, Pa
Objectives: Adipose-derived stem cells (ASCs) injected into the blood
stream after an ischemic event promote therapeutic angiogenesis in affected
tissues. It has been suggested that the stem cells exert their influence by way
of a paracrine effect on native endothelial cells (ECs). Using an in vitro
model, we evaluated the effect of ASC coculture on EC function in a hypoxic
environment.
Methods: Confluent monolayers of human ECs grown on the bottom
of transwell plates were wounded to create an even 5-mm defect and
cultured in either normoxic (21%) or hypoxic (1%) conditions.HumanASCs
were cocultured on the top of the transwell plates to evaluate a paracrine
effect. Subsequently, EC migration was determined by measuring the
wound size after 3 days. Media samples were collected, and the VEGF
concentration was measured by using ELISA. RNA from ASCs incubated in
hypoxia for varying time lengths was evaluated using PCR for various growth
